PGNY
Progyny, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$30.49
+4.92%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$29.39
From 52W high−5.78%
Volume350353.00
Market cap$2.34B
P/E (TTM)31.4x
P/S (TTM)1.8x
Div yield—
Key dataNov 4, 2026
Open
$29.39
From 52W high
−5.78%
Volume
350353.00
Market cap
$2.34B
ValuationView details →
P/E (Fwd)
21.3x
EV/EBITDA
16.8x
P/E (TTM)
31.4x
RSI (14)
68.1
MomentumView details →
1D Return
+4.92%
YTD Return
+19.16%
SummaryUpdated Jun 1, 2026
Progyny, Inc. (NASDAQ:PGNY) is a specialized benefits management company founded in 2008 and headquartered in New York. Originally incorporated as Auxogyn, Inc., the company rebranded to Progyny in 2015 and went public in October 2019. Progyny has established itself as a leading provider of fertility and family building benefits solutions for employers across the United States, serving over 530 clients with approximately 6.7 million covered lives as of 2025.
Similar companies
Latest newsMore news →
Progyny announced findings from a new clinical outcomes study showing that more than 70% of members in its Menopause and Midlife program experienced improvement in menopause symptoms.9d agoProgyny announced that it will report financial results for the quarter ended September 30, 2026, after market close on November 4, 2026.14d ago